Our evidence
| Status | Stage |
|---|---|
- Acupuncture for restless legs syndrome
- Alprazolam for essential tremor
- Amantadine for dyskinesia in Parkinson's disease
- Amantadine in Parkinson's disease
- Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials
- Anticholinergics for symptomatic management of Parkinson´s disease
- Anticonvulsants for restless legs syndrome
- Antiepileptic drugs for Tourette's syndrome
- Atypical Antipsychotics for Tourette's Syndrome
- Benzodiazepines for restless legs syndrome
- Beta-blocker therapy for tremor in Parkinson's disease
- Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)
- Botulinum toxin for drooling in Parkinson’s disease
- Botulinum toxin for masseter hypertrophy
- Botulinum toxin for motor and phonic tics in Tourette's syndrome
- Botulinum toxin type A formulations in focal dystonias
- Botulinum toxin type A therapy for blepharospasm
- Botulinum toxin type A therapy for cervical dystonia
- Botulinum toxin type A therapy for hemifacial spasm
- Botulinum toxin type A versus anticholinergics for cervical dystonia
- Botulinum toxin type A versus botulinum toxin type B for cervical dystonia
- Botulinum toxin type B for cervical dystonia
- Bromocriptine for levodopa-induced motor complications in Parkinson's disease
- Bromocriptine versus levodopa in early Parkinson's disease
- Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease
- Cabergoline for levodopa-induced complications in Parkinson's disease
- Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Cannabinoids for Tourette's Syndrome
- Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease
- Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease
- Comparison of speech and language therapy techniques for speech problems in Parkinson's disease
- Creatine for Parkinson's disease
- Deep brain stimulation for dystonia
- Dopamine agonist therapy in early Parkinson's disease
- Dopamine agonists for the treatment of restless legs syndrome
- Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
- GLP-1 receptor agonists for Parkinson's disease
- Helicobacter pylori eradication for Parkinson's disease
- Interventions for drooling in children with cerebral palsy
- Interventions for fatigue in Parkinson's disease
- Interventions for improving medication adherence in patients with idiopathic Parkinson's disease
- Interventions for preventing falls in Parkinson's disease
- Intrathecal baclofen for treating spasticity in children with cerebral palsy
- Iron for the treatment of restless legs syndrome
- Levodopa for the treatment of restless legs syndrome
- Lisuride for levodopa-induced complications in Parkinson's disease
- Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Mind-body movement therapies for Parkinson's disease
- Monoamine oxidase B inhibitors for early Parkinson's disease
- Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
- Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease
- Non-pharmacological therapies for dysphagia in Parkinson's disease
- Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies
- Occupational therapy for patients with Parkinson's disease
- Opioids for restless legs syndrome
- Pergolide for levodopa-induced complications in Parkinson's disease
- Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Pharmacotherapy for sleep bruxism
- Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis
- Physiotherapy for Parkinson's disease: a comparison of techniques
- Physiotherapy versus placebo or no intervention in Parkinson's disease
- Pimozide for tics in Tourette's syndrome
- Piribedil for levodopa-induced complications in Parkinson's disease
- Piribedil for symptomatic management of Parkinson's disease
- Piribedil versus levodopa in early Parkinson's disease
- Pramipexole for levodopa-induced complications in Parkinson's disease
- Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Pregabalin for essential tremor
- Rasagiline for levodopa-induced motor complications in Parkinson´s disease
- Ropinirole for levodopa-induced complications in Parkinson's disease
- Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Singing for people with Parkinson's disease
- Speech and language therapy interventions for speech problems in Parkinson's disease
- Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease
- Speech therapy for children with dysarthria acquired before three years of age
- Surgical treatment for the thumb-in-palm deformity in patients with cerebral palsy
- Therapeutic interventions for daytime somnolence in Parkinson's disease
- Therapeutic interventions for disease progression in Huntington's disease
- Therapeutic interventions for sleep disorders in Parkinson's disease
- Therapeutic interventions for symptomatic treatment in Huntington's disease
- Therapies for depression in Parkinson's disease
- Topiramate for essential tremor
- Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease
- Treadmill training for patients with Parkinson's disease
- Virtual reality for rehabilitation in Parkinson's disease
- Whole-body vibration training for patients with neurodegenerative disease
- Zonisamide for essential tremor
- Botulinum toxin type A injections for the treatment of lower limb spasticity in cerebral palsy
- Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease
- Constraint-induced movement therapy in the treatment of the upper limb in children with unilateral cerebral palsy
- Sleep positioning systems for children with cerebral palsy
- Speech and language therapy for children with cerebral palsy might improve their communication skills, but more research is needed.
- Trihexyphenidyl for dystonia in cerebral palsy
- Akinetic-rigid syndrome (55)
- Parkinson's disease (55)
- Therapies for depression in Parkinson's disease
- Anticholinergics for symptomatic management of Parkinson´s disease
- Beta-blocker therapy for tremor in Parkinson's disease
- Botulinum toxin for drooling in Parkinson’s disease
- Bromocriptine for levodopa-induced motor complications in Parkinson's disease
- Bromocriptine versus levodopa in early Parkinson's disease
- Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease
- Cabergoline for levodopa-induced complications in Parkinson's disease
- Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease
- GLP-1 receptor agonists for Parkinson's disease
- Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease
- Creatine for Parkinson's disease
- Dopamine agonist therapy in early Parkinson's disease
- Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
- Non-pharmacological therapies for dysphagia in Parkinson's disease
- Pramipexole for levodopa-induced complications in Parkinson's disease
- Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease
- Interventions for improving medication adherence in patients with idiopathic Parkinson's disease
- Interventions for preventing falls in Parkinson's disease
- Lisuride for levodopa-induced complications in Parkinson's disease
- Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Mind-body movement therapies for Parkinson's disease
- Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
- Monoamine oxidase B inhibitors for early Parkinson's disease
- Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson's disease
- Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease
- Pergolide for levodopa-induced complications in Parkinson's disease
- Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis
- Physiotherapy for Parkinson's disease: a comparison of techniques
- Physiotherapy versus placebo or no intervention in Parkinson's disease
- Piribedil for levodopa-induced complications in Parkinson's disease
- Piribedil for symptomatic management of Parkinson's disease
- Piribedil versus levodopa in early Parkinson's disease
- Rasagiline for levodopa-induced motor complications in Parkinson´s disease
- Ropinirole for levodopa-induced complications in Parkinson's disease
- Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease
- Singing for people with Parkinson's disease
- Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease
- Comparison of speech and language therapy techniques for speech problems in Parkinson's disease
- Speech and language therapy interventions for speech problems in Parkinson's disease
- Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease
- Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies
- Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials
- Therapeutic interventions for daytime somnolence in Parkinson's disease
- Therapeutic interventions for sleep disorders in Parkinson's disease
- Occupational therapy for patients with Parkinson's disease
- Amantadine for dyskinesia in Parkinson's disease
- Amantadine in Parkinson's disease
- Treadmill training for patients with Parkinson's disease
- Interventions for fatigue in Parkinson's disease
- Virtual reality for rehabilitation in Parkinson's disease
- Whole-body vibration training for patients with neurodegenerative disease
- Helicobacter pylori eradication for Parkinson's disease
- Parkinson's disease (55)
- Ataxia disorders (0)
- Choreo-atheoid and dyskinesias (3)
- Depression (1)
- Dystonia (8)
- Blepharospasm (1)
- Cervical dystonia (5)
- Idiopathic torsion dystonia (0)
- Hand dystonia (0)
- Hemifacial spasm (1)
- Surgical treatment (1)
- Tardive dystonia (0)
- Myoclonus (0)
- Restless legs syndrome (7)
- Anticonvulsants for restless legs syndrome
- Benzodiazepines for restless legs syndrome
- Dopamine agonists for the treatment of restless legs syndrome
- Iron for the treatment of restless legs syndrome
- Levodopa for the treatment of restless legs syndrome
- Opioids for restless legs syndrome
- Acupuncture for restless legs syndrome
- Spasticity (11)
- Cerebral palsy (9)
- Botulinum toxin type A injections for the treatment of lower limb spasticity in cerebral palsy
- Constraint-induced movement therapy in the treatment of the upper limb in children with unilateral cerebral palsy
- Interventions for drooling in children with cerebral palsy
- Intrathecal baclofen for treating spasticity in children with cerebral palsy
- Sleep positioning systems for children with cerebral palsy
- Speech and language therapy for children with cerebral palsy might improve their communication skills, but more research is needed.
- Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)
- Surgical treatment for the thumb-in-palm deformity in patients with cerebral palsy
- Trihexyphenidyl for dystonia in cerebral palsy
- Other (2)
- Cerebral palsy (9)
- Startle disorders (0)
- Stereotypies (0)
- Rett's syndrome (0)
- Tics disorders (5)
- Tremor disorders (4)
- Wilson's disease (0)